Theradiag Selected As A Partner Of The Project, The First Consortium...

... is also developing new diagnostics biomarkers thanks to its microRNA platform, in order to diagnose and monitor HIV/AIDS and rectal cancer. The Company is based in Marne-la-Vallee, near Paris, and in Montpellier, and has over 60 employees. For more ...

http://ift.tt/1hPlQNI